Santhera has begun launch preparations for AGAMREE® in UK with first sales expected in this quarter Pratteln, Switzerland, January 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that the ...
There is no Morningstar’s Analysis data available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback